CACLP 2027 to Gather Global IVD Leaders in Nanjing, China

The 24th China International In Vitro Diagnostics by CACLP will officially take place 19-21 March 2027 at the Nanjing International Expo Center in Nanjing, Jiangsu Province, China. 

Returning to Nanjing for the first time since 2010, CACLP 2027 will mark a significant new chapter for one of the world’s largest platforms for laboratory medicine and IVD. 

As China’s IVD industry continues to accelerate innovation, digital transformation, and global collaboration, CACLP continues to build an international platform connecting academia and industry, research and clinical practice, and China and international markets.

CACLP 2026 Highlights of Global Participation

Nanjing: Connected to China, Linked to the World

Located in the heart of the Yangtze River Delta, Nanjing is one of China’s most dynamic innovation and healthcare hubs. The city combines strong industrial foundations, rich scientific resources, and excellent transportation connectivity, making it an ideal destination for participants from across China and around the world.

Nanjing’s Strategic Location in China

Nanjing offers extensive opportunities for business collaboration and market expansion. The city is home to leading universities, research institutes, innovation platforms, and a strong healthcare ecosystem including 41 top-tier hospitals, while Jiangsu Province hosts a total 123 top-tier hospitals. 

Supported by a highly developed high-speed rail network, international airport, modern metro system, and strong regional economic influence, Nanjing provides efficient access to industry resources, clinical partnerships, talent, and global business opportunities. As CACLP returns to Nanjing after 17 years, the exhibition is expected to further strengthen international exchanges and create new opportunities for companies seeking growth within China and across global markets.

CACLP’s Growing Influence in the Diagnostics Sector

CACLP 2026 once again demonstrated the exhibition’s continued growth and global influence. Covering 100,000 sqms, the exhibition brought together 1,208 exhibitors across the entire IVD industry chain and welcomed 38,310 professional visitors from 55 countries and regions worldwide. International participation was once again a major highlight, with overseas attendance increasing by 26%.

Several new initiatives introduced at CACLP 2026 received highly positive feedback from exhibitors and visitors alike, including the At-home Testing Pavilion, AI Zone, and CRO Zone, as well as upgraded visitor experiences such as noise-controlled halls and dedicated networking activities for international professionals. These featured areas and services are expected to return and further expand at CACLP 2027.

Comprehensive Showcase of China’s IVD Industry

CACLP 2027 will continue to showcase the latest technologies, products, and solutions across the full spectrum of the IVD industry, including Instrument and Reagent for Laboratory Medicine, Pathology, Transfusion Medicine, and R & D, Life Sciences & Biotechnology, At-home Testing, Raw Material, Component, Consumable, Manufacturing and R&D Equipment.

Venue Layout

In parallel with the tradeshow, CACLP 2027 will host a comprehensive series of conferences, forums, matchmaking activities, and special events focusing on key industry trends and emerging opportunities. Featured themes will include AI & Digital Twin, At-home Testing, Primary Healthcare, Globalization, and Veterinary Diagnosis.

These activities will provide in-depth discussions on intelligent laboratory transformation, AI-driven innovation, consumer healthcare trends, healthcare accessibility, international expansion and the future development of the global IVD industry. By bringing together clinical experts, industry leaders, researchers, and enterprises from around the world, CACLP continues to serve as an important bridge for communication, collaboration, and innovation across the diagnostics sector.

For more information, visit en.caclp.com. For exhibitor reservations and all-year international partnership, contact info.caclp@gl-events.com.

About CACLP

With over 30 years of industry expertise, China International In Vitro Diagnostic Expo by CACLP, is well established as one of the largest exhibitions in the global in vitro diagnostic industry. Each year, it brings together more than 45,000 professionals—including entrepreneurs, scholars, users, and thought leaders from around the world—to exchange insights, foster partnerships, and collectively shape the future of IVD.

The event covers the entire diagnostics value chain from upstream to downstream, offering a comprehensive showcase of products, technologies, and services. Alongside a great number of high-level academic and educational programs held concurrently onsite, and year-round promotional solutions, CACLP continues to serve as a vital platform for global IVD players.

About GL events

Founded in Lyon in 1978, GL events is world-class leading provider of integrated solutions and services for events operating. GL events’ business covers more than 20 countries across five continents, with over 90 branches and more than 6,000 employees. GL events is listed on the Euronext Paris Segment B in 1998.

Through the unique business model – a complementary mix of products and services addressing the needs of all events and customer expectations.

 LIVE: provide comprehensive solutions from design to deliver events, 6,000 events served annually.

 VENUES: provide venues layout and operation, venues management, technical support, and more customized services, more than 60 venues under management.

 EXHIBITIONS: plan and organize tradeshows to bring together B2B & B2C communities, with 480 proprietary exhibitions.